MARKET

GHRS

GHRS

Gh Research Plc
NASDAQ
15.35
+0.97
+6.75%
After Hours: 15.35 0 0.00% 17:41 12/04 EST
OPEN
14.30
PREV CLOSE
14.38
HIGH
15.50
LOW
14.30
VOLUME
221.42K
TURNOVER
--
52 WEEK HIGH
20.50
52 WEEK LOW
6.72
MARKET CAP
952.15M
P/E (TTM)
-20.9900
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GHRS last week (1124-1128)?
Weekly Report · 3d ago
GH Research to Present Promising Results on GH001 at ACNP 2026
TipRanks · 11/24 15:48
GH Research Reports GH001 Significantly Reduces Depression and Anxiety in Treatment-Resistant Patients
Reuters · 11/24 15:19
Weekly Report: what happened at GHRS last week (1117-1121)?
Weekly Report · 11/24 09:24
GH Research PLC Reports Q3 2025 Financial Results
TipRanks · 11/21 03:58
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double
Barchart · 11/20 12:50
Weekly Report: what happened at GHRS last week (1110-1114)?
Weekly Report · 11/17 09:24
Psychedelic: Atai Beckley, Cybin report quarterly earnings
TipRanks · 11/13 16:31
More
About GHRS
GH Research PLC is a clinical-stage biopharmaceutical company. The Company is engaged in offering treatment for psychiatric and neurological disorders. The Company's pipeline includes GH001, GH002 and GH003. The Company focuses on developing its 5- Methoxy-N, N-Dimethyltryptamine, (5-MeO-DMT), therapies for the treatment of patients with Treatment Resistant Depression (TRD). Its product candidate, GH001, is formulated for 5-MeO-DMT administration via an inhalation approach. With GH001, the Company has completed two Phase 1 healthy volunteer clinical trials and a Phase 1/2 clinical trial in patients with treatment-resistant depression (TRD). The GH002 is a 5-MeO-DMT product candidate formulated for administration via an injectable approach. GH002 has completed pre-clinical development to support early clinical trials. The GH003 is a 5-MeO-DMT product candidate formulated for administration via an intranasal administration approach.

Webull offers GH Research PLC stock information, including NASDAQ: GHRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GHRS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GHRS stock methods without spending real money on the virtual paper trading platform.